Quantcast
Tag archive for ‘BioDefense Therapeutics’
By Robert On Tuesday, January 7th, 2014
2 Comments

DOD announces the first patient enrolled for Phase 3 clinical trials for broad spectrum flu drug, Favipiravir

 BioDefense Therapeutics (BD Tx)—a Joint Product Management office within the U.S. Department of Defense (DoD)—announced the first patient enrolled in the North American Phase 3 clinical trials for favipiravir More...


Recent Posts


DISPATCH BLOGS

Splash Page logo 300x146 Today in History